Gilles DELLA CORTE, MD

 

PROFESSIONAL EXPERIENCE

 

Since April 2016                CEO and Founder of DELLMED CONSULTING (Ornex-France)

Consultancy for Biotech, Start-up and Pharmas for Clinical Development strategy, Due Diligences coordination, Medical Affairs, Outsourcing, Clinical Research Organization

So far: Support to Relief Therapeutics (Start-up Geneva) for Phase I program

              Support to Maia Consulting for SAEs narratives writing for a biotech in Basel

              Support to Voisin Consulting Life Sciences for SAE narratives for a start-up in Basel, for RMP and PBRER writing for a Pharma in Paris, for CTD module 2.7.4 for a top ten big Pharma

Jan 2013 to March 2016    CLINICAL DEVELOPMENT DIRECTOR in ANERGIS SA (Lausanne)

                                           And since June 2015 VP HEAD OF CLINICAL DEVELOPMENT

Responsible for the clinical development of 3 compounds in the field of allergies (vaccine for desensitization using contiguous overlapping peptides) with the lead compound in Phase II and 2 others at preclinical stage. Budgets, planning, contracts, FDA and EMA Briefing books and advisory meetings, Phase III and Pediatric Investigational Plan preparation, presentations in congresses. Member of the Management Team. Managed the relationship with several international CROs and consultants/Steering Committee.

 

Feb 2004 to Dec 2012         Several SENIOR MEDICAL DIRECTOR positions in SERONO and then MERCK SERONO (Geneva) following successive reorganizations

Responsible for development of projects from Proof of Concept to Life Cycle Management        in different fields (Cardiology, Oncology, Rheumatology and Endocrinology)

2009-2012: Senior Medical Affairs Director

Management of Growth hormone pharmacogenomics studies program and Easypod™ Device (electronic injector pen) development

2008: Medical Advisor Exploratory Medicine

Medical advice on Translational Medicine projects e.g. Protocol advice for QT study for safinamide (Parkinson); due diligence for Tetrahydrobiopterin (BH4) in cardiovascular diseases

2007: Medical Director Global Clinical Development Unit

Medical Responsible of a POC study with IGF18 (cartilage growth factor) in knee osteoarthritis, Medical Review writing for a new indication (cartilage injury)

2004-2006: Medical Sciences Director in Experimental Medicine

Responsible for Translational Medicine projects e.g. Clinical Development Plan for IL18-BP in cardiovascular diseases; oral cladribine in Waldenström disease, efalizumab in Multiple Myeloma

               

July 2003 to Jan 2004        SCIENTIFIC and BUSINESS DEVELOPMENT DIRECTOR in THERAPHARM (CRO France)

Responsible for developing business and ensuring medical support to Clinical Operations. Acting as scientific support for the Therapharm Phase I site

 

April 2000 to Jan 2003      COUNTRY DIRECTOR FRANCE and GROUP DIRECTOR PROJECT MANAGEMENT WESTERN EUROPE in OMNICARE CLINICAL RESEARCH France (CRO, then THEOREM and CHILTERN)

General Management of the French affiliate (35 persons) and supervision of Project Teams (CRAs, Project Leaders) for France, Benelux and Spain.

 

Dec 1998 to May 1999       Clinical Research Director PHOENIX INTERNATIONAL France (CRO, then MDS Pharma Services recently acquired by INC Research)

Management of Project Leaders and CRAs (4-6 persons), logistics of Clinical Trials. Sponsors relationship for “Requests for Proposal”

 

Sep 1997 to June 1998       Medical Director in LARIME (Phase I Centre in La Rochelle, France)

Investigator for Healthy Volunteers, interface with the sponsors, Clinical Reports for Pharmacokinetic and Bioequivalence Phase I studies

 

Jan 1995 to Aug 1997        Head of the Cardiovascular Department in SOLVAY PHARMA France / Hanover (Now ABBOTT)

Medical Advisor for Clinical Development Plans for cardiology compounds in Hanover.

Set up of Phase I program for Tedisamil (treatment for arrhythmia currently marketed as Pulzium® in atrial fibrillation)

Management of Project Leaders and CRAs in France for phase I to IV clinical trials (5-7 persons). Launch of a new central hypertensive drug (moxonidine) including Price discussion with French Health Authorities (currently marketed as Physiotens® by Abbott)

 

July 1992 to Dec 1994        International Project Leader in IRIS (SERVIER LABORATORIES R&D Headquarter, France)

Full project leadership for Phase I program for ivabradine (If channels inhibitor with bradycardic effect currently marketed as Procolaran® in angina pectoris and heart failure) and medical responsible for a study with a long-acting formulation of trimetazidine (anti-ischemic drug in coronary disease)

 

Nov 1990 to June 1992       Product Specialist in PHARMUKA (RHONE-POULENC-RORER Affiliate, France, now SANOFI-AVENTIS)

Full project leadership for Phase III for Low Molecular Weight heparin (enoxaparine) used as curative treatment of venous thrombosis in France, Therapeutic Interest Overview writing for AFSSAPS (now ANSM). Marketing interface for launch preparation (KOL management, REPs training)

Set up of Phase III for beta-blocker use in heart failure (celiprolol)

 

1981-1990                          Hospital Medical Practice in Villejuif (France) Dakar (Senegal) and Marseilles (France),

Cardiology (9 semesters), Cardiac Surgery (1 semester), Nephrology (1 semester), Internal Medicine (1 semester), Internal and Tropical Medicine (3 semesters) Cancerology (1 semester)

 

INITIAL EDUCATION

 

1994                                   Cardiovascular Pharmacology Degree (PARIS V University)

1992                                   General Pharmacology Degree (PARIS XI University)

Clinical Trials Methodology Degree (DIU, AIX-MARSEILLES 2 University)

1990                                   Medical Statistics Certificate (CESAM, PARIS VI University)

1987                                   Specialization in Cardiology

Medical Doctorate

1982                                   Tropical Medicine University Diploma

1980                                   Examination as Resident (Intern) for Public Hospitals

1973-1981                          Medical Studies (Paris XI Faculty of Medicine)

 

MAIN TRAININGS

 2016                                   Mindfulness Based Stress Reduction (MBSR Geneva)

2016                                    WordPress (Groupe Si2A)

2014                                     Personal training English (CREATIVE LANGUAGE CENTER)

2012                                     Crucial confrontations (VITALSMARTS)

2012                                     Change management

2011                                     Clinical Overview Writing (DIA)

2011                                     Presentation courses (B.POIRIER)

2006, 2007, 2009          Interactive Communication courses (DIOREM)

2006                                   Individual Coaching

2005                                   Project Leadership courses (GLOBALPARTNERS)

2004                                   Team building (GLOBALPARTNERS)

2004                                   Creating new drugs (GLOBALPARTNERS)

2002                                   Proficiency assessment (MPSL)

2000                                   Training GPMP (Global Project Management Process)

1998                                    Training about Firm Creating (CEPAC) 3 months full-time

1996                                    Training on Advanced GCP (Oxford Workshops)

1991                                     Communication Training for executives (CEGOS)

1991                                       Work time Organization Training (BOSSARD)

 

AWARDS                         

 

1988                                   Appointment as “Assistant Chef de Clinique” (Consultant) by Marseilles Faculty of Medicine

1987                                     Gold Medal Resident from Medicine Faculty of Marseilles

1986                                   Laureate Searle Foundation for Hypertension Research

 

PERSONAL INFORMATION           French citizen

                                               English: fluent professional

Hobbies: fitness, yoga/mindfulness meditation, motorbike, cinema, theatre, concert, reading

Computer: Microsoft Office Suite (Word, Excel, PowerPoint, Outlook, MS Project),WordPress